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For the first time, grape seed extracts (GSEs), obtained from wine and table cultivars of Vitis vinifera L., cultured in experimental
fields of Lazio and Puglia regions of Italy and grown in different agronomic conditions, have been tested on 43 Candida species
strains. We demonstrated a significant correlation between the content of the flavan-3-ols in GSEs extracts, with a polymerization
degree≥4, and anti-Candida activity.Moreover, we demonstrated that GSEs, obtained from plants cultured with reduced irrigation,
showed a content of polymeric flavan-3-ols>250mg/gwith geometricmeanMIC values between 5.7 and 20.2mg/L againstCandida
albicans reference strains. GSE, showing 573mg/g of polymeric flavan-3-ols, has been tested in an experimental murine model of
vaginal candidiasis by using noninvasive in vivo imaging technique. The results pointed out a significant inhibition of Candida
albicans load 5 days after challenge. These findings indicate that GSEs with high content of polymeric flavan-3-ols can be used in
mucosal infection as vaginal candidiasis.
1. Introduction
Candida species are major human opportunistic fungal
pathogens that cause bothmucosal and deep tissue infections.
The frequency of mucosal and cutaneous fungal infections
has dramatically increased worldwide. Infection caused by
Candida spp. affects 70–75% of women at least once during
their life. Recurrent vulvovaginal candidiasis occurs in 5% of
women with Candida vaginitis [1, 2]. Most of these infections
are caused by Candida albicans (C. albicans) and among non-
albicans Candida spp., C. glabrata, C. tropicalis, and C. krusei.
Azoles are the most common antifungal agents available to
treat topical Candida infections. However, these antifungal
drugs have several defects related to clinical usage, such as
low efficacy and side effects.Therefore, there is an urgent need
of new antifungal agents [3]. Natural anti-infective agents
represent a promising approach for the treatment of Candida
infections [4]. Phytomedicine, which has historically been an
important aspect of traditionalmedicine in nonindustrialized
countries, is now becoming an integral part of healthcare in
industrialized countries. Plants are the source of thousands of
newphytochemicals, and different strategies can be applied to
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improve the yields of bioactivemetabolites in the plant and to
obtain chemically standardized extracts [5, 6]. Vitis vinifera
L. is the most important fruit species in the world, cultivated
especially in Mediterranean area. As reported by the wide
literature [7], grapes are rich source of polyphenols, impor-
tant secondary metabolites produced by higher plants, which
play multiple essential roles in plant physiology and showed
healthy properties in humanorganism,mainly as antioxidant,
antiallergic, anti-inflammatory, anticancer, antihypertensive,
renoprotective, and antimicrobial agents [8, 9]. GSEs are
recognized as a complex mixture of monomeric, oligomeric,
and polymeric flavan-3-ols. The principal monomers identi-
fied are (+)-catechin, (−)-epicatechin, (−)-epicatechin gallate
(ECg), (−)-epigallocatechin (EGC), and (−)-epigallocatechin
gallate (EGCg). Several fungi, including C. albicans, are
sensitive to EGCg, the main component of green tea extracts
[10]. The content of flavan-3-ols in seed grapes is influenced
by several factors mainly cultivar, irrigation, nitrogen fertil-
ization, delayed harvest, and storage conditions [11].
Moreover, the application of an extraction process suit-
able to efficiently recover the target metabolites and an
appropriate analytical method for an accurate qualitative
and quantitative determination of extract components are
required.
In this work, for the first time, anti-Candida activity and
chemical analysis of GSEs obtained from wine and table
cultivars of Vitis vinifera L. grown in different agronomic
conditions have been evaluated and comparedwith respect to
their phenolic content. The HPLC method with a Poroshell
column has allowed to quantify not only the flavan-3-ols
oligomers but also the polymeric forms (polymerization
degree >4) difficult to be detected with conventional reverse
phase columns. Moreover, the effect of GSE treatment on
an experimental murine model of vaginal candidiasis was
evaluated for the first time by using noninvasive in vivo
imaging technique.
2. Methods and Materials
2.1. Plant Material. Mature grapes were collected from dif-
ferent cultivars of Vitis vinifera L.: Michele Palieri (M.
Palieri), Italia, Red Globe, Negroamaro, Pinot, Abbuoto,
and Verdicchio. The cultivars M. Palieri, Italia, Red Globe,
and Negroamaro were grown in the experimental farm of
CRA-UTV in Turi (BA), during 2010 and 2011 with the
“tendone” system, a typical cultivation method in the Puglia
region (South Italy) whose climate is characterized by scarce
rainfalls [12]. The vines were treated with reduced irrigation
volume per hectare (1200m3) (V1) or (2000m3) (V2) and
with reduced nitrogen fertilization (120 kg ha−1) (N1) or with
180 kg ha−1 (N2) that is the quantity generally used in the
growing area. Fertilization was carried out at budding (mid-
March) and during the growth of the green grapes (first
ten days of July). The cultivars Verdicchio, Abbuoto, and
Pinot were grown in the experimental field of Lazio region
(Center of Italy), during vintages 2006, 2008, and 2011 in
normal Mediterranean conditions. The average amount of
rainfall accumulated between April and September in 2006,
in 2008, and in 2011 has been 223mm, 423mm, and 245mm,
respectively. The cultivars had training system to Cordon
Spur, with plant density of 2.60 × 1m. In the examined years
the same cultural practices were applied in the vineyard. All
the grapes were harvested at technological maturation and
frozen at −20∘C. The seeds have been isolated immediately
before use and subjected to extraction process.
2.2. Sample Preparation. The seeds were separated from the
flesh and the skin, weighed, and put in liquid nitrogen in a
porcelain mortar and ground to obtain a fine powder. They
were extracted three times (24 hrs for each extraction) by the
mixture EtOH/H
2
O (7 : 3 v/v) acidified with formic acid to
pH 3; the ratio matrix/solvent was 1 g fresh weight/10mL.
After the removal of the solid residue, the extracts were dried
(t ≤ 30∘C), weighed, and redissolved in a suitable volume of
the same extraction solution to obtain enriched extracts. The
samples were centrifuged (12.000 rpm for 5min) to obtain a
limpid solution for the HPLC/DAD/MS analyses. Only the
seeds of Abbuoto andVerdicchio cultivars (vintages 2006 and
2008) were treated with a different method using a buffer
at pH 3.2 as extractive solution. This method was applied
with the aim to simulate the wine-making process. The seeds
were manually separated from the berries and extracted with
125mL of the buffer solution for 144 hours at 30∘C.The buffer
composition consisted of tartaric acid 5 g; NaOH 1N 22mL;
Na
2
S
2
O
5
2 g; and EtOH 95% 120mL.
2.3. HPLC/DAD/MS Analysis. Themultistep elution method
was applied: it started with 95% H
2
O for 5min, then with
86%H
2
O for 25min, 84%H
2
O for 5min; 82%H
2
O for 2min,
80% H
2
O for 3min and a plateau for 4min, 70% H
2
O for
3min and a plateau for 3min, up to 20%H
2
O for 4min and a
plateau for 5min; total time of analysis 59min, equilibration
time of 10min, and a flow rate of 0.4mL/min. The column
was a Poroshell 120 EC18 (150 × 4.6mm i.d., 2.7 𝜇m) with
a precolumn of the same phase maintained at 27∘C; the
eluents were H
2
O (pH 3.2 by HCOOH) and CH
3
CN, both
of HPLC grade. The HPLC/ESI/MS analysis was carried out
using a liquid chromatographic HP 1100 L equipped with an
Electrospray (ESI) HP 1100 MDS mass detector with an API
interface. The operative conditions of the mass spectrometer
were nitrogen flux 10 Lmin−1, nebulizer pressure 30 psi,
gas temperature 350∘C, quadruple temperature 30∘C, and
capillary voltage 3000–4000V.The experiments were carried
out in negative and positive ionization modes, applying frag-
mentors between 60 and 220V.The following standards were
used for the identification: (+) catechin, (−) epicatechin, ECg,
procyanidin B1, and procyanidin B2, all of high purity grade
and purchased fromExtrasynthese (France).The quantitative
analysis of both phenol oligomers and polymers was carried
out at 280 nm using only the procyanidin B2 as external
standard in a concentration range 0.1–5.7𝜇g and a five-point
calibration curve with 𝑅2 of 0.999.
2.4. Organisms. For the in vitro antifungal evaluation, strains
coming from the American Type Culture Collection (ATCC,
Rockville, MD, USA), from the German Collection of
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Microorganisms (DSMZ, Braunschweig, Germany), and
from the Pharmaceutical Microbiology Culture Collection
(PMC, Department of Public Health and Infectious Diseases,
Sapienza, Rome, Italy) were tested. The strains coming from
ATCC were C. albicans ATCC (90028, 90029, 10261, 10231,
3153, and 24433), C. parapsilosis ATCC 22019. The strains
coming from DSMZ were C. parapsilosis DSM 11224, C.
krusei DSM 6128, and C. tropicalis DSM 11953. The strains
coming from PMC were C. albicans PMC (1011, 1075, 1083,
1088, 1097, 1002, 1004, 1006, 1008, 1010, 1012, 1018, 1031, and
1032), C. parapsilosis PMC (0703, 0711, 0706, 0704, 0705,
and 0712), C. tropicalis PMC (0908, 0910, 0912, 0913, and
0914), C. krusei PMC (0613, 0625, 0612, and 0622), and
C. glabrata PMC (0805, 0849, 0843, and 0822). For the in
vivo experiments C. albicans CA1398 carrying the ACT1p-
gLUC59 fusion (gLUC59) andC. albicansCA1399 that did not
express gLUC59 (control strain) were used [13]. The gLUC59
luciferase reporter has previously been described [13]. C.
albicans gLUC59 and the control strain were cultured in YPD
as previously described [14].
2.5. Antifungal Susceptibility Testing. The broth microdilu-
tion method to evaluate the susceptibility in vitro on strains
of Candida spp. was performed according to standardized
method for yeast [15, 16]. Briefly, the extracts were dissolved
previously in dimethyl sulfoxide at concentrations 100 times
higher than the highest test concentration [16]. The final
concentration ranged from 0.25 to 512 for total dry seed
extracts and from 0.125 to 128mg/L for Fluconazole (FLC).
Microdilution trays, containing 100 𝜇L of serial twofold
dilutions of seed extracts or FLC in RPMI 1640 medium
(Sigma-Aldrich, St. Louis, MI, USA), were inoculated with
an organism suspension of 1.0 × 103–1.5 × 103 cells/mL. The
panels were incubated at 35∘C and the growth observed
at 48 h. The minimal inhibitory concentration (MIC) was
the lowest concentration that caused a prominent decrease
(≥50%) in visible growth. The MIC
90
was defined as the low-
est drug concentration that caused ≥90% growth inhibition
compared with the drug-free control. Medians, geometric
means (GMs), and ranges were calculated.
2.6. In Vitro Induction of Resistance. C. albicans ATCC 10231
was cultured as previously described [17]. In particular, serial
subcultures of C. albicans ATCC 10231 were performed in
fresh medium every 48 hours, containing rising concentra-
tions of M. Palieri V1N1 2010GSE (starting from4mg/L up to
128mg/L). At the same time the same procedure was carried
out for the control without addition of extract. The MIC
was evaluated after 48 h of incubation (extracts concentration
range 0.5–512mg/L) according to the CLSI protocol [15].
2.7. Mice. Female CD1 mice obtained from Harlan Nossan
Laboratories (Milan, Italy) were used at 4 to 6 weeks of age.
Mice were allowed to rest for 1 week before the experiment;
by that time the animals were roughly 5 to 7 weeks old.
Mice were used under specific pathogen-free conditions that
included testing sentinels for unwanted infections; according
to the Federation of European Laboratory Animal Science
Association standards, no infections were detected.
2.8. Infection and Treatment. Mice infection was performed
as previously described with minor adaptations [18]. Mice
were maintained under pseudoestrus condition by subcu-
taneous injection of 0.2mg of estradiol valerate in 100𝜇L
of sesame oil (Sigma-Aldrich) 5 days prior to infection and
weekly until the completion of the study. Mice anaesthetized
with 2.5–3.5 (v/v) isofluorane gas were infected with 10𝜇L
of 2 × 109 cell/mL of C. albicans gLUC59 or the control
strain. Cell suspensions were administered from a mechani-
cal pipette into the vaginal lumen close to the cervix. To favor
vaginal contact and adsorption of fungal cells, mice were held
head down for 1min following inoculation. Mice were then
allowed to recover for 24–48 h, during which the Candida
infection was established. The intravaginal treatment with
FLC (200mg/L, 10 𝜇L/mouse) or with M. Palieri V1N1 2010
GSE (50mg/mL, 10 𝜇L/mouse) has begun 2 h before the
challenge and then it was repeated every two days until
day +8.
2.9. Monitoring of Mouse Vaginal Infection. After 2, 5, and 8
days after infection, 10 𝜇L (0.5 g/L in 1 : 10 methanol : H
2
O) of
coelenterazine (Synchem, OHM) was added to the vaginal
lumen. Afterwards, mice were imaged in the IVIS-200TM
imaging system (Xenogen Inc.) under anaesthesia with 2.5%
isofluorane. Total photon emission from vaginal areas within
the images (region of interest (ROI)) of each mouse was
quantified with Living ImageR software package [19].
2.10. Statistical Analysis. In order to analyze the data among
phenolic constituents andMIC values of driedGSEs obtained
from selected cultivars of Vitis vinifera L., Pearson’s corre-
lation coefficient (r) was determined. A 𝑃 value of <0.01
was considered significant. Differences between FLC and M.
Palieri V1N1 2010 GSE treated and saline treated mice were
evaluated by Mann-Whitney U-test. A value of 𝑃 < 0.05 was
considered significant.
3. Results
3.1. In Vitro Antifungal Activity of GSEs. Seed extracts
obtained by Vitis vinifera L., wine cultivars, Verdicchio and
Abbuoto, cultured in experimental fields of Lazio region of
Italy, during 2006 and 2008 vintages, showed great variability
of antifungal activity against C. albicans, with GM MIC
range from 44.22mg/L to 203.19mg/L and MIC
90
values
from 97mg/L to 256mg/L (Table 1). GSEs from the table
cultivars M. Palieri, Red Globe, and Italia grown in the
2010 in the experimental farm of CRA-UTV Puglia region
of Italy, subjected to reduction of irrigation volume (V1
and V2) and different nitrogen fertilization (N1 and N2),
showed potent and comparable antifungal activity against
C. albicans with a range of GM MIC values from 8.2mg/L
to 12.8mg/L and MIC
90
values from 17.9mg/L to 29.8mg/L
(Table 2). Moreover, antifungal activity against non-albicans
Candida spp. showed MIC values from 6.5 to 8.6mg/L and
MIC
90
values from 14 to 18mg/L (Table 3).The same cultivars
harvested in 2011 and grown under the same agronomic
conditions showed MIC values from 5.66 to 14.59mg/L
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Table 1: Antifungal activity against Candida albicans reference strains of GSEs from table and wine cultivars of Vitis vinifera L. harvested in
different years.
Candida albicans Verdicchio 2006 Verdicchio 2008 Abbuoto 2006 Abbuoto 2008 Fluconazole
MIC MIC
90
MIC MIC
90
MIC MIC
90
MIC MIC
90
MIC MIC
90
ATCC90028 64 128 256 256 64 128 64 512 0.5 8
ATCC3153 64 128 256 256 32 64 32 128 16 32
ATCC10261 64 128 256 128 32 64 64 128 4 32
ATCC10231 32 64 128 256 64 128 64 128 2 32
ATCC24433 128 256 512 256 128 128 128 128 1 16
GM 53.20 97.01 203.19 256 44.22 97 64 168.9 3.03 24.25
Range 32–128 32–256 128–512 128–512 32–128 64–128 32–128 128–512 0.5–16 8–32
The values are expressed as median of minimum inhibitory concentration (MIC) determined using Clinical and Laboratory Standard Institute (CLSI) protocol
M27-A3. MIC90: lowest drug concentration that prevented 90% of growth with respect to the untreated control. GM: geometrical mean of MIC.
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Figure 1: Chromatographic profiles at 280 nm of GSEs from Pinot 2011 (a), M.Palieri V1N1 2010 (b), and M. Palieri V1N1 2011 (c). (+) cat:
(+)-catechin; proc B2: procyanidin B2; (−) epicat: (−)-epicatechin; ECg: epicathechin gallate; Pol 1 and Pol 2: polymeric flavan-3-ols with
galloylated residues and a degree of polymerization ≥4, determined by mass spectrometry.
and MIC
90
values from 17.55 to 29.17mg/L for C. albicans
reference strains demonstrating that the antifungal activity is
reproducible over the years (Table 4). Negroamaro V2N2 and
V1N2 (fromPuglia region) grown in 2011 revealedMICvalues
against C. albicans reference strains of 10.7mg/L, 20.2mg/L,
respectively (samples 13 and 14 of Table 5), while Pinot
(from Lazio region), not subjected to controlled agronomic
conditions of water and nitrogen, showed MIC values of
84.5mg/L (sample 15 of Table 5).
3.2. Chemical Composition of the Extracts. An example of the
GSEs HPLC profiles in terms of monomers, oligomers, and
polymers is shown in Figure 1. Optimizing the chromato-
graphic method also with the help of an RP 18 Poroshell
column several monomer and oligomer compounds have
been separated and quantified in all the fifteen extracts
(Table 5). The identification of the phenols listed in Table 5
has been done by mean of their UV and mass spectra, by
the use of pure standards ((+) catechin; (−) epicatechin;
procyanidin B1 and B2; ECg) and according to the literature
[20–22]. Moreover, two groups of polymeric procyanidins
(Pol 1 and Pol 2) with a polymerization degree ≥4 have been
separated and determined by their mass spectra in negative-
ionization mode (Figure 1 and Table 5).
The chemical composition of the different extracts corre-
lated to their antifungal activity against C. albicans reference
strains is summarized in Table 5. The identified components
in the GSEs typically belong to the flavan-3-ols class; (+)
catechin and (−) epicatechin are the main monomers; within
the polymeric forms 1 + 2 (from 40 to 96% of the total
flavan-3-ols) are included some acylated forms with gallic
acid residues. The extracts 1–4 and 15 (Table 5) showed the
lowest content of flavan-3-ols and in particular the lowest
content of polymeric forms compared with all the other
samples (Table 5).
3.3. Antifungal Activity of M. Palieri V1N1 2010 GSE against
Vaginal Candidiasis. M. Palieri V1N1 2010GSE has been
chosen for in vivo test for best reproducibility of M. Palieri
cultivar, confirmed in different years, in MIC values and in
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Table 5: Phenolic constituents and MIC values of dried GSEs obtained from fifteen selected cultivars of Vitis vinifera L.
Sample Flavan-3-olsmg/g
Pol 1 + 2
mg/g
GMon + Olig
mg/g
Pol 1 + 2/
flavan-3-ols Pol 1/Pol 2
Pol 2
mg/g
MIC GM
mg/L
1 Verdicchio 2006 198.3 156.5 4.9 0.79 1.6 60.2 53.2
2 Abbuoto 2006 96.9 67.2 3.1 0.69 3.5 14.9 44.2
3 Verdicchio 2008 69.1 32.8 4.1 0.47 4.2 6.3 203.2
4 Abbuoto 2008 98.1 38.9 10.10 0.40 6.2 5.4 64.0
5 M. PalieriV2N1 2010 820.0 638.5 25.2 0.78 2.8 168.0 10.6
6 M. PalieriV1N1 2010 748.1 572.9 23.4 0.77 2.9 146.9 11.6
7 M. PalieriV2N1 2011 581.1 465.4 18.2 0.80 2.8 122.4 12.1
8 M. PalieriV1N1 2011 617.6 448.8 20.7 0.73 4.0 89.8 14.6
9 ItaliaV2N2 2011 460.4 429.0 11.9 0.93 2.7 115.9 6.1
10 ItaliaV1N2 2011 534.2 514.5 5.4 0.96 1.7 190.9 5.7
11 Red GlobeV2N1 2011 471.7 404.9 28.4 0.86 3.6 88.0 7.0
12 Red GlobeV1N1 2011 300.5 251.6 23.1 0.84 4.4 46.6 12.1
13 NegroamaroV2N2 2011 375.3 354.4 2.4 0.94 2.2 110.7 10.7
14 NegroamaroV1N2 2011 401.7 306.7 9.0 0.76 4.1 60.1 20.2
15 Pinot 2011 229.5 143.2 11.4 0.62 3.4 32.5 84.5
Flavan-3-ols: total sum of monomers, oligomers (degree of polymerization ≤ 3) and polymeric forms; Pol 1 + 2: polymeric forms (degree of polymerization
≥ 4); G (gallate) Mon (monomers) + Olig (oligomers) is the sum of (−) epicatechin gallate, monogalloylated dimer, monogalloylated dimer of type A, and
monogalloylated trimer. MIC GM: geometric mean MIC against Candida albicans reference strains (ATCC90028, ATCC3153, ATCC10261, ATCC10231, and
ATCC24433) determined using Clinical and Laboratory Standard Institute (CLSI) protocol M27-A3.
phenolic constituents. Moreover, we demonstrated that M.
Palieri V1N1 2010 GSE treatment did not induce in vitro
resistance on C. albicans ATCC 10231. The MIC value was of
16mg/L both for control and for M. Palieri V1N1 2010 GSE-
treated strain. The in vitro antifungal activity of MP V1N1
2010GSE and FLC, againstC. albicans gLUC59 used in in vivo
test, showed MIC values of 15.6 ± 12.7 and 0.60 ± 0.20mg/L,
respectively.
Antifungal activity of M. Palieri V1N1 2010 GSE against
vaginal candidiasiswasmonitored in an experimentalmurine
model of vaginal candidiasis that allowed the visualization
of the temporal and spatial progression of infection. In
particular the M. Palieri V1N1 2010 GSE was administered
intravaginally (50 g/L, 10 𝜇L/mouse) 2 h before the challenge
and then it was repeated every two days until day +8. The
results reported in Figure 2 showed a significant inhibition
of C. albicans load observed 5 days after challenge. The effect
was comparable to that observed with FLC.The infection was
completely cleared 8 days after infection (Figure 2).
4. Discussion
In this work, for the first time, the in vitro anti-Candida
activity of GSE from wine and table cultivars of Vitis vinifera
L., grown in different agronomic conditions, collected over
several years has been evaluated. The results showed that
GSEs obtained from cultivars grown in Puglia under hydric
stress possess potent antifungal activity in vitro, in some cases
similar to that of FLC itself. All GSEs have been chemically
characterized. A significant negative correlation coefficient
of total flavan-3-ols contained in the different extracts and
MIC values has been demonstrated (𝑟 = −0.648, 𝑃 =
0.00896). Moreover, we demonstrated for the first time that
the antifungal activity (MIC) of GSEs is attributable mostly
to the polymeric flavan-3-ols (with a polymerization degree
≥4), with a significative negative correlation coefficient (𝑟 =
−0.6974, 𝑃 = 0.0038) (Table 5). Differently, the content
of gallate monomers and oligomers did not seem to be
correlated to antifungal activity (𝑟 = −0.4334, 𝑃 = 0.1065). It
is important to emphasize that the typical catechin of green
tea, EGCg, known to be responsible of growth-inhibitory
effect on clinical isolates of Candida spp. [10], is absent in our
samples.
We demonstrated that Verdicchio and Abbuoto, not sub-
jected to controlled agronomic conditions of water, collected
in 2006 (samples 1-2), had a higher content of polymers 1 + 2
(with the polymer 2 from 3- to 10-fold higher) than the same
cultivars collected in 2008 (Table 5). These differences could
be partially attributable to the rainfall during 2008, twofold
higher than that in 2006.
Hydric stress implies a bigger effort to absorb water from
the soil and, as a consequence, a lesser vegetative growth
and an increase of bioactive molecules production [23]. In
particular, Cavaliere et al. demonstrated that the content of
flavan-3-ols in grape seeds is influenced by several agronomic
conditions mainly irrigation and nitrogen fertilization [11,
24].
In the present work, the dried GSEs obtained from the
cultivars M. Palieri, Italia, Red Globe, and Negroamaro, cul-
tured under hydric stress (V1 and V2) (samples 5–14 Table 5),
showed the highest content of polymers 1 + 2 >250mg/g with
the polymer 2 >46mg/g and the best antifungal activity with
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Figure 2: In vivo imaging of mice vaginally infected with C. albicans gLUC59 and treated with Fluconazole (FLC) or M. Palieri V1N1 2010
GSE (V1N1).Mice under pseudoestrus condition were infected intravaginally with 10𝜇L of a 2×109 cell/mL suspension ofC. albicans gLUC59
and treated with 10 𝜇L of saline, 10𝜇L of FLC (200mg/L), or 10 𝜇L of V1N1 (0.5 g/L) 2 h before the challenge and then every two days. After 2,
5, and 8 days after infection mice were treated intravaginally with 10𝜇L of coelenterazine (0.5 g/L) and imaged in the IVIS-200TM imaging
system under anesthesia with 2.5% isofluorane. Total photon emission from vaginal areas within the images (region of interest (ROI)) of each
mouse was quantified with Living ImageR software package. The reported data come from one of the three experiments with similar results
(a). Quantification of total photon emission from ROI was evaluated and the statistical significance was determined with Mann-Whitney
U-test. 𝑃 = 0.04762 (Day +2 postchallenge FLC-treated versus saline-treated mice); 𝑃 = 0.01587 (Day +5 postchallenge FLC-treated versus
saline-treated mice) and 𝑃 = 0.00794 (Day +5 postchallenge V1N1-treated versus saline-treated mice) (b).
the GM MIC values between 5.7 and 20.2mg/L against C.
albicans reference strains (Table 5) as reported in the patent
PCT/IT2011/000400 [25].
GSE, with 573mg/g of polymeric flavan-3-ols, obtained
fromM. Palieri V1N1 2010, has been tested in an experimental
murine model of vaginal candidiasis, by using noninvasive in
vivo imaging technique.This GSE demonstrated to accelerate
the clearance of fungus during vaginal candidiasis, with
a significant inhibition of C. albicans load 5 days after
challenge, evaluated by photon emission.
5. Conclusion
In conclusion, we demonstrated that GSEs obtained from
Vitis vinifera plants, grown under hydric stress, had a high
and reproducible content of polymeric flavan-3-ols, with
10 BioMed Research International
a polymerization degree≥4, and high antifungal activity. Fur-
ther studies are in progress to characterize these polymeric
fractions.
Moreover, we demonstrated, for the first time, anti-
Candida activity of GSE in an experimental murine model
of vaginal candidiasis.
These findings, together with lack of toxicity and easy way
of preparation of the extracts, suggest that GSEs with high
content of polymeric flavan-3-ols could be used in Candida
infections.
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